Relevant bibliographies by topics / Rosiglitazone

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Rosiglitazone'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rosiglitazone.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Rosiglitazone"

1

Okami, Nobuya, Purnima Narasimhan, Hideyuki Yoshioka, et al. "Prevention of JNK Phosphorylation as a Mechanism for Rosiglitazone in Neuroprotection after Transient Cerebral Ischemia: Activation of Dual Specificity Phosphatase." Journal of Cerebral Blood Flow & Metabolism 33, no. 1 (2012): 106–14. http://dx.doi.org/10.1038/jcbfm.2012.138.

Full text
Abstract:
Rosiglitazone, a synthetic peroxisome proliferator-activated receptor-γ (PPARγ) agonist, prevents cell death after cerebral ischemia in animal models, but the underlying mechanism has not been clarified. In this study, we examined how rosiglitazone protects neurons against ischemia. Mice treated with rosiglitazone were subjected to 60 minutes of focal ischemia followed by reperfusion. Rosiglitazone reduced infarct volume after ischemia and reperfusion. We show that this neuroprotective effect was reversed with a PPARgM antagonist. Western blot analysis showed a significant increase in expressi
APA, Harvard, Vancouver, ISO, and other styles
2

Bogatkevich, Galina S., Kristin B. Highland, Tanjina Akter та Richard M. Silver. "The PPARγAgonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects". Pulmonary Medicine 2012 (2012): 1–9. http://dx.doi.org/10.1155/2012/545172.

Full text
Abstract:
We present novel data demonstrating that the expression of PPARγis reduced in lung fibroblasts from black SSc-ILD patients as compared to white patients. Activating PPARγwith the agonist rosiglitazone increased the expression of MMP-1 and inhibited collagen type I in lung fibroblasts isolated from white, but not black, SSc-ILD patients. Blocking the c-Met receptor abolishes rosiglitazone's effects on collagen and MMP-1 in lung fibroblasts isolated from white SSc-ILD patients, while augmenting the expression of the c-Met receptor in fibroblasts from black SSc-ILD patients replicates the effects
APA, Harvard, Vancouver, ISO, and other styles
3

Lu, Wenyi, Kaiyan Liu, Weimin Wang, Shujuan Wang, and Yonghuai Feng. "Long-Term Treatment with Rosiglitazone Delays Hematopoietic Recovery in Response to Stress." Blood 126, no. 23 (2015): 4769. http://dx.doi.org/10.1182/blood.v126.23.4769.4769.

Full text
Abstract:
Abstract Rosiglitazone is a peroxisome proliferator activated receptor-γ(PPAR-γ) agonist available to improve glucose metabolism in patients with Type 2 diabetes. Recent evidence suggests that therapeutic use of rosiglitazone have caused unwanted hematological side effects, such as anemia, leukopenia, thrombocytopenia, even pancytopenia. However, others reported that pretreatment with rosiglitazone for 5 days could protect against 5-Fu-induced myelotoxity which is FLT3 dependent. Thus, it is still unclear the exact effects of rosiglitazone treatment on homeostatic and stress hematopoiesis. Ros
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 1180 (2007): 34. http://dx.doi.org/10.2165/00128415-200711800-00107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 1186 (2008): 33. http://dx.doi.org/10.2165/00128415-200811860-00106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 1127 (2006): 21. http://dx.doi.org/10.2165/00128415-200611270-00070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 1143 (2007): 21. http://dx.doi.org/10.2165/00128415-200711430-00070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 788 (2000): 9–10. http://dx.doi.org/10.2165/00128415-200007880-00030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 788 (2000): 10. http://dx.doi.org/10.2165/00128415-200007880-00031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Rosiglitazone." Reactions Weekly &NA;, no. 850 (2001): 11. http://dx.doi.org/10.2165/00128415-200108500-00028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Rosiglitazone"

1

Pereira, Lúciano Artur Lopes. "Characterization of the sympathomimetic action of rosiglitazone." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2009. http://hdl.handle.net/10216/53524.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pereira, Lúciano Artur Lopes. "Characterization of the sympathomimetic action of rosiglitazone." Dissertação, Faculdade de Medicina da Universidade do Porto, 2009. http://hdl.handle.net/10216/53524.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Matos, Amélio Fernando de Godoy. "Relação entre a Síndrome Metabólica, teor de gordura intramiocelular e os níveis plasmáticos da Adiponectina: papel da Rosiglitazona." Universidade do Estado do Rio de Janeiro, 2009. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=1421.

Full text
Abstract:
A resistência à insulina está associada com o aumento do teor de gordura intramiocelular (GIMC) e com níveis séricos da adiponectina (ADP) diminuídos. A ADP por sua vez está envolvida na oxidação de gordura muscular. Entretanto, a relação entre ambas continua controversa. O objetivo deste estudo é explorar a relação entre a ADP e a GIMC em adultos não diabéticos, além de estudar o papel da rosiglitasona (RSG) sobre a distribuição da gordura entre os compartimentos musculares. Este estudo compreende duas fases: uma fase transversal (corte-transversal) e uma fase longitudinal, de intervenção ter
APA, Harvard, Vancouver, ISO, and other styles
4

McClure, Lauren Elizabeth. "Best of Both Worlds: Linking Nitric Oxide Donors and Rosiglitazone." Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/321882.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ali, Tomader Faroug Mohammed. "Protection of pancreatic beta cells by Rosiglitazone : mechanisms and pathways." Thesis, University of Brighton, 2011. https://research.brighton.ac.uk/en/studentTheses/a2865a73-c579-4bf0-a80f-2b609425cc17.

Full text
Abstract:
The thiazolidinedione Rosiglitazone can protect pancreatic beta cells from the detrimental effects of free fatty acids. The aim of this study was to determine the differential effects of saturated fatty acids on beta cells and to identify the mechanisms through which Rosiglitazone can protect beta cell viability. Utilising the mouse beta cell line MIN6, transmission electron microscopy (TEM) was used to determine the effects of palmitate and Rosiglitazone on lipid uptake and cell ultra-structure. H/PI staining and MTT assays were used to determine cell viability.
APA, Harvard, Vancouver, ISO, and other styles
6

Sidhu, Jagdip Singh. "The effects of rosiglitazone, a peroxisome proliferator-activated receptor γ ligand, on atherosclerosis." Thesis, St George's, University of London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.407397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ferreira, Iolanda João Mora Cruz de Freitas. "Pre and postjunctional effects of rosiglitazone on the isolated rat aorta and heart." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2010. http://hdl.handle.net/10216/61097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ferreira, Iolanda João Mora Cruz de Freitas. "Pre and postjunctional effects of rosiglitazone on the isolated rat aorta and heart." Dissertação, Faculdade de Medicina da Universidade do Porto, 2010. http://hdl.handle.net/10216/61097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dias, Cristiano. "Rosiglitazone pode causar lesão tubular renal em ratos normais mas não em ratos hipercolesterolêmicos." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5148/tde-25022010-160938/.

Full text
Abstract:
Introdução: Rosiglitazone (RGL) é um ligante dos receptores PPAR e vem sendo usada no tratamento do Diabetes Mellitus tipo 2 e nas doenças inflamatórias. Mas, RGL pode reduzir a filtração glomerular (FG), a carga excretada de sódio na urina (UVNa) e aumentar a expressão da Na+,K+- ATPase na medula renal. Então, RGL pode causar edema e insuficiência cardíaca congestiva. Entretanto, não tem sido reportado se RGL pode induzir insuficiência renal aguda (IRA). Objetivo: Verificar se a redução da FG causada pelo tratamento com RGL predispõe à IRA em ratos. Avaliar em condições basais e de vasoconstr
APA, Harvard, Vancouver, ISO, and other styles
10

Woods, Sally. "Comparison of metformin, rosiglitazone, and acetaminophen in the prevention of olanzapine toxicity in mice." University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1305892985.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Rosiglitazone"

1

Parker, Philip M., and James N. Parker. Rosiglitazone: A medical dictionary, bibliography, and annotated research guide to Internet references. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Canadian Coordinating Office for Health Technology Assessment., ed. Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents. Canadian Coordinating Office for Health Technology Assessment, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

HOPPE, Joyce. Avandia Rosiglitazone. Independently Published, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kayla, Carl. Avandia Rosiglitazone. Independently Published, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Blokdijk, G. J. Rosiglitazone Maleate; Complete Self-Assessment Guide. CreateSpace Independent Publishing Platform, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rosiglitazone - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Duplisea, J. Kevin. A pilot study to describe the efficacy of metformin versus rosiglitazone in HIV patients receiving protease inhibitors. 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Rosiglitazone"

1

Uçmak, Gülin, and Burcu Esen Akkaş. "Rosiglitazone Effect on Radioiodine Uptake in a Case of Dedifferentiated Thyroid Carcinoma." In Thyroid and Parathyroid Diseases. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-78476-2_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sahin, Ali. "Insulin-Sensitizing Antihyperglycemic Drugs." In Current Perspective on Diabetes Mellitus in Clinical Sciences. Nobel Tip Kitabevleri, 2023. http://dx.doi.org/10.69860/nobel.9786053359111.10.

Full text
Abstract:
Insulin-sensitizing antihyperglycemic drugs are a class of medications used in the management of diabetes mellitus, particularly type 2 diabetes, by improving the body’s response to insulin. One prominent group within this category is the thiazolidinediones (TZDs), which include drugs like pioglitazone and rosiglitazone. These medications act primarily by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which play a key role in regulating glucose and lipid metabolism. By enhancing insulin sensitivity in peripheral tissues such as muscle, adipose tissue, and liver,
APA, Harvard, Vancouver, ISO, and other styles
3

Meisner, F., A. Noack, A. Cihlar, et al. "Rosiglitazon stabilisiert atherosklerotische Plaques." In Chirurgisches Forum 2006. Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/3-540-34668-6_153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Day, Caroline, and Clifford J. Bailey. "Rosiglitazone." In xPharm: The Comprehensive Pharmacology Reference. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.62558-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Day, C., and C. J. Bailey. "Rosiglitazone☆." In Reference Module in Biomedical Sciences. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-12-801238-3.97237-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Rosiglitazone." In Hale’s Medications & Mothers’ Milk™ 2019. Springer Publishing Company, 2018. http://dx.doi.org/10.1891/9780826150356.0913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Rosiglitazone (r)." In Drugs Handbook 2012–2013. Bloomsbury Academic, 2011. http://dx.doi.org/10.5040/9781350363595.art-1531.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Patti, Mary-Elizabeth, Mark Callery, Robert Najarian, et al. "Case 93: Progressive Hypoglycemia Due to Insulinoma in a Patient with Type 2 Diabetes: Treatment with Image-Guided Minimally Invasive Pancreas-Sparing Surgery." In Diabetes Case Studies: Real Problems, Practical Solutions. American Diabetes Association, 2015. http://dx.doi.org/10.2337/9781580405713.93.

Full text
Abstract:
A 54-year-old man with type 2 diabetes (T2D) presented for evaluation of hypoglycemia. T2D was diagnosed at age 35 years, when the patient presented with recurrent urinary tract infections. Treatment with diet, metformin, and pioglitazone/rosiglitazone led to normalization of glucose, with hemoglobin A1c of 6%. He remained stable until age 54 years, when he developed an inferior wall myocardial infarction (MI). Postinfarction pericarditis required initiation of higher dose aspirin (650 mg t.i.d.). Patient markedly improved diet and increased exercise in the post-MI setting, achieving a rapid 2
APA, Harvard, Vancouver, ISO, and other styles
9

Jimenez-Serrania, Maria-Isabel. "Data Mining Strategy to Prevent Adverse Drug Events: The Cases of Rosiglitazone and COVID-19 Vaccines." In Research Advances in Data Mining Techniques and Applications [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.112412.

Full text
Abstract:
This chapter analyzes how a simple strategy of early detection of safety signals using data mining can prevent the potential risk of adverse events with new or former drugs. We first present the case of an active antidiabetic ingredient, rosiglitazone. The capability of the strategy to detect the risk of heart failure among the data reported during the first 8 years of commercialization was demonstrated 2 years before rosiglitazone was withdrawn from the market in 2020 due to that risk. Ten years later, agility in obtaining safety signals after marketing a drug was put to the test with COVID-1
APA, Harvard, Vancouver, ISO, and other styles
10

Tzimopoulou Sofia, Cunningham Vincent J., Nichols Thomas E., et al. "Validation and Pilot Application of [." In Advances in Alzheimer’s Disease. IOS Press, 2011. https://doi.org/10.3233/978-1-60750-793-2-627.

Full text
Abstract:
Here we describe methods for application of quantitative fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) measures of brain glucose metabolism in multi-centre clinical trials for Alzheimer's disease. We validated methods and demonstrated their use in the context of a treatment trial with the PPARγ agonist Rosiglitazone XR versus placebo in mild to moderate AD patients. Novel quantitative indices related to the combined forward rate constant for [18F]FDG uptake \(({K}_{i}^{index})\) and to the rate of cerebral glucose utilization \((CM{R}_{glu}^{index})\) were applied. A
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Rosiglitazone"

1

Cugno, Chiara, Ganesh Halade, and Md Mizanur Rahman. "Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging mice." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0099.

Full text
Abstract:
Rosiglitazone is an effective insulin-sensitizer, however, associated with bone loss mainly due to increased bone resorption, and bone marrow adiposity, and decreased bone formation. We investigated the effect of the co-administration of fish oil (FO) rich in omega-3 fatty acids (FAs) on rosiglitazone (RSG)-induced bone loss in aging C57BL/6 mice and the mechanisms underlying potential preventive effect. Mice fed the iso-caloric diet supplemented with fish oil exhibited significantly higher levels of bone density in different regions compared to the other groups. In the same cohort of mice, re
APA, Harvard, Vancouver, ISO, and other styles
2

Song, Eun-Kee, Ho-Young Yhim, Jun-Mo Yim, et al. "Abstract 4413: Rosiglitazone prevents graft-versus-host disease (GVHD)." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4413.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Benkő, Klára, Éva Pintye, Boglárka Szabó, et al. "Effect of Rosiglitazone on Radiation Damage in Bone Marrow Hemopoiesis." In RADIATION DAMAGE IN BIOMOLECULAR SYSTEMS: Proceedings of the 5th International Conference (RADAM 2008). AIP, 2008. http://dx.doi.org/10.1063/1.3058979.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ward, JE, J. Tran, SR Foster, SG Royce, ML Tang та SR Bailey. "Bronchodilator Actions of Rosiglitazone in Isolated Mouse Trachea Are PPARγ-Independent." У American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Silva, AG, DM Laks, CB Magalhaes, et al. "Pulmonary Effects of Rosiglitazone in Rats Treated with Isoproterenol for One Week." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a6070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bourke, Jane E., James Esposito, Yan Bai, and Mike Sanderson. "Rosiglitazone Inhibits Small Airway Contraction And Calcium Signalling In Mouse Lung Slices." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1262.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tabuso, Maria, Raghu Adya, Mark Christian, and Ramesh P. Arasaradnam. "PWE-056 Rosiglitazone: a potential new stroma targeted therapeutic agent in colon cancer." In British Society of Gastroenterology Annual Meeting, 17–20 June 2019, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-bsgabstracts.380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sakurai, R., E. Shin, J. Corral, J. Torday та V. Rehan. "Antenatal Administration of PPARγ Agonist Rosiglitazone (RGZ) Prevents Hyperoxia-Induced Lung Injury Postnatally." У American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Oberlick, Elaine, LaTonia D. Taliaferro-Smith, Wayne Harris, et al. "Abstract 1078: Rosiglitazone inhibits breast cancer growth and proliferation via cyclin D1 inhibition." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ibrahim, Khadega, Chiara Cugno, and Md Mizanur Rahman. "Conjugated Linoleic Acid (CLA) co-treatment alleviates antidiabetic drug, rosiglitazone associated deterioration of bone remodeling." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0148.

Full text
Abstract:
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to decreased insulin secretion, defective action or both. The rosiglitazone (RSG) is one of the oral antidiabetic drug used in type 2 (T2) DM and has a unique insulin-sensitizing capacity. However, RSG has a negative side effect on the bone as it stimulates the differentiation of bone marrow-mesenchymal stromal cells (BM-MSCs) into adipocytes at the expense of osteoblasts in the bone marrow microenvironment, disturbing the normal balance of bone remodeling and causing BM adiposity. On the other hand, the t
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Rosiglitazone' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography